Time course of pain response and toxicity after whole-nerve-encompassing LINAC-based stereotactic radiosurgery for trigeminal neuralgia—a prospective observational study; [Zeitverlauf von Schmerzansprechen und Toxizität nach LINAC-basierter stereotaktischer Radiochirurgie der gesamten Nervenzirkumferenz bei Trigeminusneuralgie – eine prospektive Beobachtungsstudie]

被引：0

作者：

Koca S. ^{[1
]}

Distel L. ^{[1
]}

Lubgan D. ^{[1
]}

Weissmann T. ^{[1
]}

Lambrecht U. ^{[1
]}

Lang-Welzenbach M. ^{[1
]}

Eyüpoglu I. ^{[2
]}

Bischoff B. ^{[2
]}

Buchfelder M. ^{[2
]}

Semrau S. ^{[1
]}

Fietkau R. ^{[1
]}

Lettmaier S. ^{[1
]}

Putz F. ^{[1
]}

机构：

[1] Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nuremberg, Universitaetsstraße 27, Erlangen

[2] Department of Neurosurgery, Friedrich-Alexander-University Erlangen-Nuremberg, Schwabachanlage 6, Erlangen

来源：

Strahlentherapie und Onkologie | 2019年 / 195卷 / 8期

关键词：

Facial pain; Radiosurgery; SRS; Toxicity; Trigeminal neuralgia;

D O I：

10.1007/s00066-019-01450-9

中图分类号：

学科分类号：

摘要：

Purpose: To prospectively evaluate the time course of pain response and toxicity after linear accelerator-based whole-nerve-encompassing radiosurgery (LINAC-SRS) using a uniform treatment schedule for dosing and target volume definition in patients with refractory trigeminal neuralgia. Methods: From December 2012 to December 2016, 21 patients were treated using a standardized protocol. Patients received LINAC-SRS with 70 Gy to the cisternal portion while aiming for the 90% isodose to fully envelope the nerve in one cross-sectional plane. Data on pain, analgesics, and toxicity were gathered prospectively. Four time intervals (1–6, 6–12, 12–18, and 18–24 months) were defined and compared to baseline and each other. Results: The median follow-up from radiotherapy was 16 months. Freedom from pain was achieved at least once in 90.5, 81.0, and 85.7% of patients for everyday pain, rest pain, and pain peaks, respectively. At 1–6 months, pain was significantly reduced in everyday routine (mean VAS, 2.0/10 vs. 5.8/10; P = 0.004), at rest (1.5/10 vs. 4.0/10; P = 0.002), and for pain peaks (2.9/10 vs. 10/10; P < 0.001), as was the number of analgesics (mean 1.5 vs. 2.9; P < 0.001). No significant increase in pain or analgesics was observed for subsequent time intervals. At last follow-up, reduction in pain compared to baseline for everyday routine (2.1/10 vs. 5.8/10; P = 0.010) and for pain peaks (3.3/10 vs. 10/10; P < 0.001) was significant, whereas it was not for rest pain (1.8/10 vs. 3.9/10; P = 0.073). Most toxicities were related to trigeminal nerve impairment, with 42.9% reporting new-onset hypoesthesia at last follow-up. Conclusion: This study provides prospective data after whole nerve encompassing LINAC-SRS for trigeminal neuralgia. No significant pain relapse was observed. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature.

引用

页码：745 / 755

页数：10

共 36 条

[21]

Rogers C.L., Shetter A.G., Fiedler J.A., Smith K.A., Han P.P., Speiser B.L., Gamma knife radiosurgery for trigeminal neuralgia: the initial experience of The Barrow Neurological Institute, Int J Radiat Oncol Biol Phys, 47, 4, pp. 1013-1019, (2000)

[22]

Chen J.C., Greathouse H.E., Girvigian M.R., Miller M.J., Liu A., Rahimian J., Prognostic factors for radiosurgery treatment of trigeminal neuralgia, Neurosurgery, 62, pp. A53-A60, (2008)

[23]

Parikh R.R., Goodman R.R., Rhome R., Sudentas E., Trichter F., Harrison L.B., Choi W., Linear accelerator-based flattening-filter-free stereotactic radiosurgery for trigeminal neuralgia: feasibility and patient-reported outcomes, Pract Radiat Oncol, 6, 1, pp. e1-e7, (2016)

[24]

Smith Z.A., Gorgulho A.A., Bezrukiy N., McArthur D., Agazaryan N., Selch M.T., De Salles A.A., Dedicated linear accelerator radiosurgery for trigeminal neuralgia: a single-center experience in 179 patients with varied dose prescriptions and treatment plans, Int J Radiat Oncol Biol Phys, 81, 1, pp. 225-231, (2011)

[25]

Pokhrel D., Sood S., McClinton C., Saleh H., Badkul R., Jiang H., Stepp T., Camarata P., Wang F., Linac-based stereotactic radiosurgery (SRS) in the treatment of refractory trigeminal neuralgia: detailed description of SRS procedure and reported clinical outcomes, J Appl Clin Med Phys, 18, 2, pp. 136-143, (2017)

[26]

Goss B.W., Frighetto L., DeSalles A.A., Smith Z., Solberg T., Selch M., Linear accelerator radiosurgery using 90 gray for essential trigeminal neuralgia: results and dose volume histogram analysis, Neurosurgery, 53, 4, pp. 823-828, (2003)

[27]

Xue J., Goldman H.W., Grimm J., LaCouture T., Chen Y., Hughes L., Yorke E., Dose-volume effects on brainstem dose tolerance in radiosurgery, J Neurosurg, 117, pp. 189-196, (2012)

[28]

Young B., Shivazad A., Kryscio R.J., St Clair W., Bush H.M., Long-term outcome of high-dose gamma knife surgery in treatment of trigeminal neuralgia, J Neurosurg, 119, 5, pp. 1166-1175, (2013)

[29]

Tuleasca C., Carron R., Resseguier N., Donnet A., Roussel P., Gaudart J., Levivier M., Regis J., Decreased probability of initial pain cessation in classic trigeminal neuralgia treated with gamma knife surgery in case of previous microvascular decompression: a prospective series of 45 patients with 〉1 year of follow-up, Neurosurgery, 77, 1, pp. 87-94, (2015)

[30]

Gorgulho A., De Salles A.A., McArthur D., Agazaryan N., Medin P., Solberg T., Mattozo C., Ford J., Lee S., Selch M.T., Brainstem and trigeminal nerve changes after radiosurgery for trigeminal pain, Surg Neurol, 66, 2, pp. 127-135, (2006)

← 1 2 3 4 →